July 13, 2009 - The new ProCure Proton Therapy Center in Oklahoma City celebrated its official grand opening on July 8, 2009, where patients with head and neck, brain, central nervous system, prostate and some pediatric cancers will be treated at the new Center

The center is the first in a network of ProCure centers, which treat patient with proton therapy, to open across the country. ProCure has a second center under construction in the suburbs of Chicago, scheduled to open in early 2011; and centers in development in New Jersey, south Florida and Detroit, Mich.

According to Procure Inc., there is a need for protons that is not accommodated for, as an estimated 250,000 patients could benefit from proton therapy annually while only 6,000 treatment slots are available through the five centers that have been operating to date.

The Procure Proton Therapy Center in Oklahoma City is affiliated with INTEGRIS Health, the largest Oklahoma-owned, not-for-profit health system in the state. INTEGRIS is opening the cancer institute adjacent to the proton therapy Center and will provide treatment and services to patients who may need additional care while undergoing proton therapy.

The 60,000-square-foot center will have four treatment rooms with a treatment capacity of 1,500 patients a year. Patients will be chosen according to medical appropriateness and evaluated by a physician review board. Patients under treatment will have personal care teams of medical professionals who will remain with them throughout their treatment. The team will involve patients’ personal physicians to allow for a continuum of care.

For more information: www.procure.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now